Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The latest developments in insulin injection devices.

K E Robertson1, N B Glazer1, R K Campbell2

  • 1Eli Lilly and Company, Indianapolis, Indiana, USA.

The Diabetes Educator
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.

Clinical pharmacology and therapeutics·2016
Same author

A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).

Diabetes, obesity & metabolism·2016
Same author

Validating a refractometer to evaluate immunoglobulin G concentration in Jersey colostrum and the effect of multiple freeze-thaw cycles on evaluating colostrum quality.

Journal of dairy science·2014
Same author

Effect of test environment on expression of clines and on delimitation of seed zones in Douglas-fir.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Sex pheromone of hickory shuckwormCydia caryana Development of an effective field Lure.

Journal of chemical ecology·2013
Same journal

Correction to 'Competencies for Diabetes Care and Education Specialists' by Ryan et al. <i>The Diabetes Educator</i> 46(4), pages 384-397 (August 2020).

The Diabetes educator·2020
Same journal

<i>The Diabetes Educator</i> (<i>TDE</i>): Successes, Opportunities, and Future Changes.

The Diabetes educator·2020
Same journal

An Umbrella Review of Text Message Programs for Adults With Type 2 Diabetes.

The Diabetes educator·2020
Same journal

Community-Based Participatory Research Interventions to Improve Diabetes Outcomes: A Systematic Review.

The Diabetes educator·2020
Same journal

"Together We Can Return to Balance"-Eastern Woodlands Native Perspectives and Type 2 Diabetes: A Qualitative Study.

The Diabetes educator·2020
Same journal

The Healthy Eating and Living Against Noncommunicable Diseases Study: An Innovative Family-Based Intervention.

The Diabetes educator·2020
See all related articles

Technological advancements are transforming diabetes treatment, empowering patients with more information. This increased knowledge allows for greater patient autonomy in managing diabetes and choosing insulin delivery devices, with ongoing education crucial for optimal outcomes.

Area of Science:

  • Endocrinology
  • Medical Technology
  • Diabetes Management

Background:

  • Diabetes treatment is evolving rapidly due to technological advancements.
  • Patients with diabetes have increased access to information regarding their condition and treatment options.
  • This heightened awareness is fostering greater patient autonomy in managing diabetes.

Purpose of the Study:

  • To highlight the impact of technology on future diabetes treatment.
  • To emphasize the growing role of patient autonomy in treatment decisions.
  • To underscore the importance of informed choices in selecting insulin delivery devices.

Main Methods:

  • Review of current technological trends in diabetes care.
  • Analysis of patient access to and utilization of health information.

Related Experiment Videos

  • Assessment of patient preparedness for making informed decisions on diabetes management tools.

    • Main Results:

    • Significant technological developments are anticipated in diabetes care over the next few years.
    • Patients are increasingly autonomous in managing their diabetes.
    • Patients are better equipped to make informed decisions about insulin delivery systems.

    Conclusions:

    • Technological progress is reshaping diabetes treatment paradigms.
    • Empowered and informed patients are key to adopting new diabetes management technologies.
    • Continuous education and follow-up by diabetes educators are essential for maximizing the benefits of new insulin delivery technologies.